Evidence map›Paper›PMID 32876014›Full record

ArticleThe American journal of tropical medicine and hygiene2020

No Evidence of Acute Dengue Virus Infections at a Rural Site in Western Kenya, 2011 and 2013.

Alastair I Matheson, Ondari D Mogeni, Joshua R Lacsina, Melvin Ochieng, Allan Audi, Godfrey Bigogo, John Neatherlin, Harold S Margolis, Barry Fields, Petronella Ahenda and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Alastair I MathesonDepartment of Global Health, University of Washington, Seattle, Washington.
Ondari D MogeniCentre for Global Health Research, Kenya Medical Research Institute, Nairobi, Kenya.
Joshua R LacsinaDepartment of Medicine, University of Washington, Seattle, Washington.
Melvin OchiengKenya Medical Research Institute/Centers for Disease Control and Prevention, Nairobi, Kenya.
Allan AudiKenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.
Godfrey BigogoKenya Medical Research Institute/Centers for Disease Control and Prevention, Kisumu, Kenya.
John NeatherlinKenya Medical Research Institute/Centers for Disease Control and Prevention, Nairobi, Kenya.
Harold S MargolisDengue Branch, Division of Vectorborne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Barry FieldsDivision of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.
Petronella AhendaSchool of Public Health, Texas A&M University, College Station, Texas.
Judd L WalsonDepartment of Medicine, University of Washington, Seattle, Washington.
Joel M MontgomeryDivision of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · KEUniversity of Washington · USCenters for Disease Control and Prevention · USKenya Medical Research Institute · KEPuerto Rico Department of Health · PRTexas A&M University · US

Funding

Institute of Translational Health SciencesTL1TR000422 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$2.1M
NCATS NIH HHS TL1 TR000422
6 · The paper itself

Abstract

The incidence and spread of dengue virus (DENV) have increased rapidly in recent decades. Dengue is underreported in Africa, but recent outbreaks and seroprevalence data suggest that DENV is widespread there. A lack of ongoing surveillance limits knowledge about its spatial reach and hinders disease control planning. We sought to add data on dengue distribution in Kenya through diagnostic testing of serum specimens from persons with an acute febrile illness (AFI) attending an outpatient clinic in rural western Kenya (Asembo) during rainy seasons. Patients with symptoms not likely to be misclassified as dengue (e.g., diarrhea and anemia), those with a positive diagnostic laboratory results which explained their febrile illness, or those with serum collected more than 5 days after fever onset were excluded. However, febrile patients with a positive malaria smear were included in the study. We used reverse transcription polymerase chain reaction (RT-PCR) to test for DENV and IgM anti-DENV to test for recent infection. Of the 615 serum specimens available for testing, none were dengue positive by either RT-PCR or IgM anti-DENV testing. Dengue did not appear to be a cause of febrile illness in this area of western Kenya, although our relatively small sample size may not have identified DENV infections occurring at low incidence. A more widespread AFI surveillance system that includes dengue diagnostic testing by RT-PCR and antibody-based methods is required to more definitively gauge the size and geographic distribution of DENV infection in western Kenya.

Indexed as

Acute DiseaseAdolescentAdultChildChild, PreschoolDengueDengue VirusEpidemiological MonitoringFemaleFeverHumansInfantKenyaMaleYoung Adult

Identifiers

PMID32876014
PMCPMC7646792
OpenAlexW3082293147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.